The GI-specific Avoidance Scale (GIAS): Development, psychometric validation, and incremental power of a new questionnaire

This study presents the development and psychometric validation of the GI-specific Avoidance Scale (GIAS), a robust 20-item, three-factor questionnaire that effectively measures GI-specific avoidance and demonstrates significant incremental validity in predicting symptom severity and psychological distress among patients with chronic gastrointestinal conditions.

The Gist

Imagine you have a stomach that sometimes acts up, causing pain, bloating, or urgency. It's not just the physical pain that's hard to deal with; it's the fear of those symptoms happening in the wrong place (like at a dinner party or on a long bus ride).

Because of this fear, people often start building invisible walls around their lives. They stop eating certain foods, avoid going out, or even stop being intimate with their partners because they are terrified of an accident or embarrassment.

This paper is about building a specialized ruler to measure exactly how high those walls are.

Here is the story of the paper, broken down simply:

1. The Problem: We Needed a Better Ruler

Before this study, doctors and psychologists had a few tools to measure how sick people felt or how much they avoided things in general. But these tools were like using a thermometer to measure wind speed. They were close, but they didn't capture the specific, unique ways people with gut problems (like IBS or IBD) avoid things.

They needed a tool that could measure the specific ways these patients hide, restrict their diets, or pull away from loved ones because of their stomach issues.

2. The Solution: The "GIAS" (The Avoidance Detective)

The researchers created a new questionnaire called the GI-specific Avoidance Scale (GIAS). Think of it as a detective that asks 20 specific questions to figure out how much a person is "hiding" from their symptoms.

They started with 58 questions (a long list of suspects) and narrowed it down to the best 20 based on what experts and patients said was most important.

3. The Three "Walls" (The Three Factors)

When they analyzed the answers, they found that people build three distinct types of walls. The GIAS measures all three:

• The General Wall (General Avoidance): This is the "I'm going to hide my whole life" wall. It includes things like planning every trip around where the bathroom is, staying home because you're afraid of symptoms, or trying to distract yourself so you don't think about your stomach.
• The Food Wall (Food Avoidance): This is the "I'm scared to eat" wall. It's not just about being hungry; it's about being terrified that a specific meal will trigger a disaster. People might stop eating out or restrict their diet so much they miss out on nutrition and joy.
• The Intimacy Wall (Intimacy & Body Exposure): This is the "I'm ashamed of my body" wall. It involves avoiding sex, not wanting to be naked in front of a partner, or feeling too embarrassed to change clothes in public because of the fear of gas or accidents.

4. Testing the Ruler (Validation)

The researchers tested this new ruler on 102 people with gut problems. They compared the GIAS results with other known measures of anxiety, shame, and quality of life.

• The Results: The ruler worked perfectly.
  • People who scored high on the GIAS (meaning they had high avoidance) also reported higher shame, more severe symptoms, and lower quality of life.
  • People who scored low on the GIAS (meaning they were more flexible and accepting) felt better and had less anxiety.
• The "Extra" Power: The GIAS was so good that it could predict symptoms and anxiety better than the old, general illness questionnaires. It found details the old tools missed.

5. The Vicious Cycle (The Mediation)

The study also looked at the relationship between Symptoms and Distress (anxiety/depression).

Imagine a seesaw. Usually, when symptoms go up, distress goes up. The study found that Avoidance is the heavy weight sitting in the middle of that seesaw.

• Symptoms cause fear.
• Fear causes Avoidance (hiding, restricting).
• Avoidance actually makes the symptoms feel worse and the distress higher in the long run.

The GIAS helps us see that avoidance is the engine driving the cycle of suffering.

Why Does This Matter?

Think of this new scale as a GPS for therapy.

If a doctor knows a patient is stuck in the "Food Wall," they can use specific exposure therapy to help them try new foods safely. If a patient is stuck in the "Intimacy Wall," therapy can focus on body image and shame.

In short: This paper gave us a new, precise map to understand how people with gut problems are trying to protect themselves, but often trapping themselves in the process. Now, doctors can use this map to help patients tear down those walls and live freer, less anxious lives.

Technical Summary

1. Problem Statement

Individuals with chronic gastrointestinal (GI) conditions frequently engage in experiential avoidance (e.g., restricting food, avoiding social situations, or suppressing thoughts about symptoms) to manage anticipated distress or shame. While avoidance is a known transdiagnostic mechanism underlying psychopathology and functional impairment, the field lacks a validated, comprehensive, GI-specific assessment tool.

• Limitations of existing tools: Current instruments like the Visceral Sensitivity Index (VSI) only partially address avoidance, and general measures like the Illness Behavior Avoidance Scale (IBAS) fail to capture the specific content and context of GI-related behaviors (e.g., dietary restrictions, intimacy issues, or body image concerns).
• Consequence: The absence of a specific measure hinders accurate clinical assessment, the evaluation of intervention mechanisms (such as Acceptance and Commitment Therapy), and the tailoring of treatment plans.

2. Methodology

The study employed a quantitative cross-sectional design to develop and validate the GI-specific Avoidance Scale (GIAS).

• Participants:
  • Sample: 102 Portuguese adults (Mean age = 40.8 years; predominantly female) with medically diagnosed GI conditions (primarily Irritable Bowel Syndrome [IBS] and Inflammatory Bowel Disease [IBD]).
  • Recruitment: Targeted outreach via social media and national patient associations.
  • Exclusion: Participants failing attention checks or those who were pregnant were excluded.
• Scale Development Process:
  • Item Generation: An initial pool of 58 items was generated based on literature, clinical theory (ACT model), and multidisciplinary expert consensus (psychologists, gastroenterologists, dietitians).
  • Refinement: Items were rated by 3 experts and 1 patient representative. Items with a mean relevance score $\ge$ 2.5 were retained, resulting in a 37-item preliminary scale.
• Measures:
  • Target: GIAS (6-point Likert scale).
  • Convergent/Discriminant Validity Measures: IBAS (general illness avoidance), CompACT-8 (psychological flexibility), CISS (illness shame), SCS-SF (self-compassion), DASS-21 (depression/anxiety), EUROHIS-QOL-8 (quality of life), and a self-report GI symptom inventory.
• Statistical Analysis:
  • Exploratory Factor Analysis (EFA): Principal axis factoring with oblimin rotation to determine factor structure.
  • Reliability: Cronbach's alpha for internal consistency.
  • Validity: Pearson correlations, hierarchical regression (for incremental validity), and mediation analysis (PROCESS macro, Model 4) to test bidirectional relationships between symptoms and distress.

3. Key Contributions

The primary contribution is the creation and validation of the GIAS, the first self-report instrument specifically designed to measure behavioral and cognitive avoidance unique to GI populations.

• Multidimensional Structure: The scale identifies three distinct, clinically meaningful factors:
  1. General Avoidance: Broad psychological and behavioral avoidance (e.g., cognitive suppression, safety-seeking, social withdrawal).
  2. Food Avoidance: Dietary restriction driven by fear of symptom triggering.
  3. Intimacy and Body Exposure Avoidance: Avoidance of sexual intimacy and physical vulnerability due to shame or fear of incontinence/visible symptoms.
• Differentiation from ARFID: The authors clarify that while the Food Avoidance subscale overlaps with Avoidant/Restrictive Food Intake Disorder (ARFID) behaviors, the GIAS is distinct in measuring avoidance specifically triggered by GI symptom fears rather than a primary eating disorder diagnosis.

4. Results

• Factor Structure: EFA on the 37-item pool resulted in a 20-item, three-factor solution.
  • Factor 1 (General Avoidance): 11 items (37.64% variance).
  • Factor 2 (Food Avoidance): 5 items (6.16% variance).
  • Factor 3 (Intimacy/Body Exposure): 4 items (5.36% variance).
  • Note: 17 items were removed due to low loadings, cross-loadings, or high inter-item correlations.
• Reliability:
  • Total Scale: Excellent internal consistency ($\alpha = .94$).
  • Subscales: Good to excellent ($\alpha = .82$ to $.94$).
• Convergent Validity:
  • GIAS scores correlated positively with illness shame, GI symptom severity, and psychological distress (anxiety/depression).
  • GIAS scores correlated negatively with psychological flexibility, self-compassion, and quality of life.
  • Nuance: The Food Avoidance subscale showed weaker associations with general psychological distress compared to the other factors, suggesting it may be a more behaviorally specific dimension.
• Incremental Validity:
  • Hierarchical regression showed that GIAS explained unique variance in GI symptom severity and anxiety levels above and beyond the general illness avoidance measure (IBAS).
  • IBAS did not significantly predict GI symptoms, whereas GIAS did.
• Mediation Analysis:
  • GIAS was found to be a partial mediator in the bidirectional relationship between GI symptoms and psychological distress.
  • GI symptoms $\rightarrow$ Avoidance $\rightarrow$ Distress (Indirect effect significant).
  • Distress $\rightarrow$ Avoidance $\rightarrow$ GI Symptoms (Indirect effect significant).
  • The models explained ~29-30% of the variance in the dependent variables.

5. Significance and Implications

• Clinical Utility: The GIAS provides clinicians with a precise tool to assess specific avoidance patterns (e.g., distinguishing between general social withdrawal and specific food fears), allowing for more targeted treatment planning.
• Therapeutic Mechanism: The findings support the theoretical model that avoidance is a maintaining factor in the cycle of GI symptoms and distress. This validates the use of exposure-based and acceptance-based therapies (like ACT) that specifically target these GI-related avoidance behaviors.
• Research Advancement: The scale fills a critical gap in psychometric tools, enabling future longitudinal studies to track changes in avoidance during interventions and clarifying the specific mechanisms driving functional impairment in GI populations.
• Limitations & Future Directions: The study is cross-sectional (limiting causal inference) and relies on self-report. Future research requires Confirmatory Factor Analysis (CFA), test-retest reliability, and validation across diverse cultural and diagnostic groups.

In conclusion, the GIAS is a psychometrically robust, multidimensional instrument that significantly advances the assessment of GI-specific avoidance, offering new avenues for both clinical intervention and research into the psychological management of chronic gastrointestinal disorders.